Memory	memory	O	O	O	O
facilitation	facilitation	O	O	O	O
and	and	O	O	O	O
stimulation	stimulation	O	O	O	O
of	of	O	O	O	O
endogenous	endogenous	O	O	O	O
nerve	nerve	CHEMICALS	O	OTHERS	I
growth	growth	CHEMICALS	O	OTHERS	I
factor	factor	CHEMICALS	O	OTHERS	I
synthesis	synthesis	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
acetylcholine	acetylcholine	CHEMICALS	O	OTHERS	I
releaser	releaser	O	O	O	O
PG-9.The	pg-9.the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
PG-9	pg-9	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
3alpha-tropyl	3alpha-tropyl	O	O	O	O
2-(p-bromophenyl)propionate	2-(p-bromophenyl)propionate	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
acetylcholine	acetylcholine	CHEMICALS	O	OTHERS	I
releaser	releaser	O	O	O	O
,	,	O	O	O	O
on	on	O	O	O	O
memory	memory	O	O	O	O
processes	processes	O	O	O	O
and	and	O	O	O	O
nerve	nerve	CHEMICALS	O	OTHERS	I
growth	growth	CHEMICALS	O	OTHERS	I
factor	factor	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
NGF	ngf	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
synthesis	synthesis	O	O	O	O
were	were	O	O	O	O
evaluated	evaluated	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
mouse	mouse	O	O	O	O
passive-avoidance	passive-avoidance	O	O	O	O
test	test	O	O	O	O
,	,	O	O	O	O
PG-9	pg-9	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
10	10	O	O	O	O
-	-	O	O	O	O
30	30	O	O	O	O
mg/kg	mg/kg	O	O	O	O
,	,	O	O	O	O
i.p	i.p	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
administered	administered	O	O	O	O
20	20	O	O	O	O
min	min	O	O	O	O
before	before	O	O	O	O
the	the	O	O	O	O
training	training	O	O	O	O
session	session	O	O	O	O
,	,	O	O	O	O
prevented	prevented	O	O	O	O
amnesia	amnesia	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
both	both	O	O	O	O
the	the	O	O	O	O
non	non	O	O	O	O
selective	selective	O	O	O	O
antimuscarinic	antimuscarinic	O	O	O	O
drug	drug	O	O	O	O
scopolamine	scopolamine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
M1-selective	m1-selective	O	O	O	O
antagonist	antagonist	O	O	O	O
S-(-)-ET-126	s-(-)-et-126	O	O	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
experimental	experimental	O	O	O	O
conditions	conditions	O	O	O	O
,	,	O	O	O	O
PG-9	pg-9	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
5	5	O	O	O	O
-	-	O	O	O	O
20	20	O	O	O	O
microg	microg	O	O	O	O
per	per	O	O	O	O
mouse	mouse	O	O	O	O
,	,	O	O	O	O
i.c.v	i.c.v	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
also	also	O	O	O	O
able	able	O	O	O	O
to	to	O	O	O	O
prevent	prevent	O	O	O	O
antimuscarine-induced	antimuscarine-induced	O	O	O	O
amnesia	amnesia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
demonstrating	demonstrating	O	O	O	O
a	a	O	O	O	O
central	central	O	O	O	O
localization	localization	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
activity	activity	O	O	O	O
.	.	O	O	O	O

At	at	O	O	O	O
the	the	O	O	O	O
highest	highest	O	O	O	O
effective	effective	O	O	O	O
doses	doses	O	O	O	O
,	,	O	O	O	O
PG-9	pg-9	CHEMICALS	O	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
produce	produce	O	O	O	O
any	any	O	O	O	O
collateral	collateral	O	O	O	O
symptoms	symptoms	O	O	O	O
as	as	O	O	O	O
revealed	revealed	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
Irwin	irwin	O	O	O	O
test	test	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
it	it	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
modify	modify	O	O	O	O
spontaneous	spontaneous	O	O	O	O
motility	motility	O	O	O	O
and	and	O	O	O	O
inspection	inspection	O	O	O	O
activity	activity	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
revealed	revealed	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
hole-board	hole-board	O	O	O	O
test	test	O	O	O	O
.	.	O	O	O	O

PG-9	pg-9	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
also	also	O	O	O	O
able	able	O	O	O	O
to	to	O	O	O	O
increase	increase	O	O	O	O
the	the	O	O	O	O
amount	amount	O	O	O	O
of	of	O	O	O	O
NGF	ngf	CHEMICALS	O	OTHERS	I
secreted	secreted	O	O	O	O
in	in	O	O	O	O
vitro	vitro	O	O	O	O
by	by	O	O	O	O
astrocytes	astrocytes	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
manner	manner	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
maximal	maximal	O	O	O	O
NGF	ngf	CHEMICALS	O	OTHERS	I
contents	contents	O	O	O	O
obtained	obtained	O	O	O	O
by	by	O	O	O	O
PG-9	pg-9	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
17.6-fold	17.6-fold	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
control	control	O	O	O	O
value	value	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
culture	culture	O	O	O	O
,	,	O	O	O	O
no	no	O	O	O	O
morphological	morphological	O	O	O	O
changes	changes	O	O	O	O
were	were	O	O	O	O
found	found	O	O	O	O
at	at	O	O	O	O
effective	effective	O	O	O	O
concentrations	concentrations	O	O	O	O
of	of	O	O	O	O
PG-9	pg-9	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
current	current	O	O	O	O
work	work	O	O	O	O
indicates	indicates	O	O	O	O
the	the	O	O	O	O
ability	ability	O	O	O	O
of	of	O	O	O	O
PG-9	pg-9	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
induce	induce	O	O	O	O
beneficial	beneficial	O	O	O	O
effects	effects	O	O	O	O
on	on	O	O	O	O
cognitive	cognitive	O	O	O	O
processes	processes	O	O	O	O
and	and	O	O	O	O
stimulate	stimulate	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
NGF	ngf	CHEMICALS	O	OTHERS	I
synthesis	synthesis	O	O	O	O
in	in	O	O	O	O
astroglial	astroglial	O	O	O	O
cells	cells	O	O	O	O
.	.	O	O	O	O

Therefore	therefore	O	O	O	O
,	,	O	O	O	O
PG-9	pg-9	CHEMICALS	O	OTHERS	I
could	could	O	O	O	O
represent	represent	O	O	O	O
a	a	O	O	O	O
potential	potential	O	O	O	O
useful	useful	O	O	O	O
drug	drug	O	O	O	O
able	able	O	O	O	O
to	to	O	O	O	O
improve	improve	O	O	O	O
the	the	O	O	O	O
function	function	O	O	O	O
of	of	O	O	O	O
impaired	impaired	O	O	O	O
cognitive	cognitive	O	O	O	O
processes	processes	O	O	O	O
.	.	O	O	O	O

